evaluate the pharmaceuticals company wegovy on glp-1 efficacy / effectiveness FDA approves first-ever oral GLP-1RA for obesity and chronic weight management. Meet (semaglutide) tablets. https://www.prnewswire.com/news-releases/fda-approves-novo-nordisks-wegovy -pill-the-first-and-only-oral-glp-1-for-weight-loss-in-adults Compare GLP-1 Options | Ozempic

Participants who received semaglutide had greater reductions in the number of heavy drinking days (41% fewer, on average) compared to those receiving placebo (26%.) The amount of alcohol consumed over the prior 30 days dropped by over 70% in the semaglutide group (from 78 ounces of 100% alcohol at baselinethe equivalent of 130 shots of 80-proof spirits over 30 daysto 23 ounces, or about 39 shots)

GLP-1 analogue-loaded glucose-responsive nanoparticles as allies of stem cell therapies for the treatment of type I diabetes

Information presented reflects publicly available brand materials and independent ingredient research

Reviewed by Emily Bigby, MD, Physician with Ivm Health Disclaimer: The information presented reflects clinical observations and emerging research